fda warning letters glp-1 compounders september 2025 news National Hispanic Medical Association | The federal government is stepping up to stop counterfeit weight-loss drugs. In 2025, bipartisan lawmakers urged stronger enforcement In a recent "secret shopper"

Beyond about 200mg, absorption drops dramatically, and excess is excreted

The substantial weight reduction from semaglutide GLP-1 use not only helps in managing and reducing the risks associated with obesity-related health conditions such as heart disease but also enhances overall well-being

This is the pattern I keep running into in practice: clinical demand outpaces the systems meant to govern it, and the clinicians closest to patients are left interpreting ambiguity in real time, with no monograph, no FDA-approved product, and often no clear precedent, while still being accountable for the outcome

Levothyroxine Absorption: The Key Practical Consideration The most important drug interaction consideration for people with hypothyroidism on GLP-1 medications is levothyroxine absorption